THROMAXILLIN

This brand name is authorized in Nigeria.

Active ingredients

The drug THROMAXILLIN contains one active pharmaceutical ingredient (API):

1	Azithromycin UNII 5FD1131I7S - AZITHROMYCIN DIHYDRATE
	Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.
	Read more about Azithromycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-1591	Film coated tablet	Thromaxillin+++ TAB_FILM_COATED 500 mg 2 x 3's; 1 x 10's	Film coated caplet White capsule shaped, biconvex, film coated tablet embossed 'N' on one side and plain on the other side 10/30/2024 13:21:09 THROMAXILLIN AZITHROMYCIN B4-1591 FILM COATED TABLET ORAL AZITHROMYCIN 500MG 2 X 3; 1 X 10 POM NEMEL PHARMACEUTICALS LIMITED PLOT 35 EMENE INDUSTRIAL LAYOUT, EMENE, ENUGU, NIGERIA NEMEL PHARMACEUTICALS LIMITED PLOT 35 EMENE INDUSTRIAL LAYOUT, EMENE, ENUGU STATE, NIGERA NIGERIA 29/03/2021 28/03/2026 Yes J01FA10	29/03/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01FA10	Azithromycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FA Macrolides
Discover more medicines within J01FA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-1591